Laquinimod Uses, Dosage, Side Effects and more
Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well tolerated orally.
| Attribute | Details |
|---|---|
| Trade Name | Laquinimod |
| Generic | Laquinimod |
| Laquinimod Other Names | Laquinimod |
| Type | |
| Formula | C19H17ClN2O3 |
| Weight | Average: 356.81 Monoisotopic: 356.0927701 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in multiple sclerosis.
